Publication:
Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls

dc.contributor.authorHergenç, Gülay
dc.contributor.authorBudak, Yasemin
dc.contributor.authorTaga, Yavuz
dc.contributor.buuauthorİlçöl, Yeşim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentBiyokimya Ana Bilim Dalı
dc.contributor.researcheridAAL-8873-2021
dc.date.accessioned2022-01-03T08:55:25Z
dc.date.available2022-01-03T08:55:25Z
dc.date.issued1999-11
dc.identifier.citationHergenç, G. vd. (1999). "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls". Clinical Chemistry, 45(11), 2050-2050.
dc.identifier.endpage2050
dc.identifier.issn0009-9147
dc.identifier.issue11
dc.identifier.startpage2050
dc.identifier.urihttp://hdl.handle.net/11452/23811
dc.identifier.volume45
dc.identifier.wos000083440300055
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherOxford University Press
dc.relation.collaborationYurt içi
dc.relation.journalClinical Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMedical laboratory technology
dc.subject.wosMedical laboratory technology
dc.titleApo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Biyokimya Ana Bilim Dalı
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: